MacroGenics, Inc.
MacroGenics, Inc. is focused on discovering and developing antibody-based cancer therapies.
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying MacroGenics' stock with a target price of $10.8, indicating strong growth potential.
Financial Health
MacroGenics is generating strong revenue and cash flow, supported by a high gross margin.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring MGNX
Pharma M&A Targets: Biotech Stocks to Watch 2025
AbbVie is spending $2.7 billion on external R&D, highlighting a major industry trend of large pharmaceutical companies acquiring innovation. This creates a potential opportunity among the smaller biotech firms that are becoming prime acquisition targets.
Published: October 5, 2025
Explore BasketNavigating U.S. Drug Price Reforms
The White House is demanding major pharmaceutical companies slash U.S. drug prices, creating significant market volatility and threatening industry profits. This creates a potential opening for companies that offer cost-saving alternatives, such as generic drug makers and healthcare service providers.
Published: August 5, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Clinical catalysts ahead
Multiple upcoming trial readouts can materially move the share price; these events are high‑impact but outcomes are binary and can be volatile.
Engineering antibodies
Fc‑engineering and bispecific platforms may create differentiated treatments, though technical and regulatory challenges remain that can delay progress.
Partnerships matter
Collaborations and licensing deals can provide funding and commercial reach, but the benefits depend on execution and market uptake.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals develops treatments for diseases including cystic fibrosis and cancer.
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals is a leading biotechnology company that develops and manufactures innovative medicines for serious medical conditions.
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing therapeutics based on RNA interference (RNAi).
